Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by MindMed MindMed to Participate at May Investor Conferences May 09, 2024 From MindMed Via Business Wire Tickers MNMD MindMed Reports First Quarter 2024 Financial Results and Business Updates May 08, 2024 From MindMed Via Business Wire Tickers MNMD MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York May 04, 2024 From MindMed Via Business Wire Tickers MNMD MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update May 02, 2024 From MindMed Via Business Wire Tickers MNMD MindMed to Present at Upcoming May Medical Conferences April 25, 2024 From MindMed Via Business Wire Tickers MNMD MindMed Announces Voluntary Delisting from Cboe Canada April 01, 2024 From MindMed Via Business Wire Tickers MNMD MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference March 11, 2024 From MindMed Via Business Wire Tickers MNMD MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120 March 01, 2024 From MindMed Via Business Wire Tickers MNMD MindMed Reports 2023 Financial Results and Business Updates February 28, 2024 From MindMed Via Business Wire Tickers MNMD MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update February 22, 2024 From MindMed Via Business Wire Tickers MNMD MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference February 07, 2024 From MindMed Via Business Wire Tickers MNMD MindMed to Participate in the TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit September 14, 2023 From MindMed Via Business Wire Tickers MNMD MindMed Reports Second Quarter 2023 Financial Results and Business Highlights August 03, 2023 From MindMed Via Business Wire Tickers MNMD MindMed Urges Shareholders to Vote TODAY for Company Nominees Ahead of June 13th Deadline June 09, 2023 From MindMed Via Business Wire Tickers MNMD Leading Proxy Advisory Firm ISS Recommends MindMed Shareholders Vote FOR All Six Company Nominees June 05, 2023 From MindMed Via Business Wire Tickers MNMD MindMed to Present Data on the Preclinical Activity of MM-402 at the American Society of Clinical Psychopharmacology (ASCP) 2023 Annual Meeting May 24, 2023 From MindMed Via Business Wire Tickers MNMD MindMed Announces Enrollment Milestone in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD) May 17, 2023 From MindMed Via Business Wire Tickers MNMD MindMed Reports First Quarter 2023 Financial Results and Business Highlights May 04, 2023 From MindMed Via Business Wire Tickers MNMD MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy May 02, 2023 From MindMed Via Business Wire Tickers MNMD MindMed to Participate in May Investor Conferences April 26, 2023 From MindMed Via Business Wire Tickers MNMD MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting April 18, 2023 From MindMed Via Business Wire Tickers MNMD MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD) April 14, 2023 From MindMed Via Business Wire Tickers MNMD MindMed Appoints Mark R. Sullivan as Chief Legal Officer and Corporate Secretary April 13, 2023 From MindMed Via Business Wire Tickers MNMD MindMed Reports Full Year 2022 Financial Results and Business Highlights March 09, 2023 From MindMed Via Business Wire Tickers MNMD MindMed to Participate in March Investor Conferences February 28, 2023 From MindMed Via Business Wire Tickers MNMD Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.